Business
Kuniko goes deep to light up NSW polymetallic riches
By Katherine Langford
Sydney Morning Herald Business
Amplia uncovers new clue in pancreatic cancer drug trial
Amplia Therapeutics has advanced its cancer drug narmafotinib across four trials, with data suggesting it may work independently of common tumour-causing KRAS gene mutations.
Up nextKuniko goes deep to light up NSW polymetallic richesBusiness · 1 min read
More Business stories
Business
Ping-pong tables won’t save your office – but these 10 things will
By Katherine Langford
Sydney Morning Herald Business
Business
Rare earths resource boost in sight as Red Metal drills Qld giant
By Katherine Langford
Sydney Morning Herald Business
Business
Sky’s not the limit: $5 trillion sci-fi deal could bring Musk closer to Mars
By Marcus Chen
Sydney Morning Herald Business